Article: Poor Survival in COVID-19 Associated with Lymphopenia and Higher Neutrophile-Lymphocyte Ratio.
The Israel Medical Association journal : IMAJ
2021 Volume 23, Issue 3, Page(s) 153–159
Abstract: ... μL, B cells CD19+ ≥ 80/μL, and NK ≥ 34/μL subsets were associated with survival in severe COVID-19 ... in severe COVID-19 (odds ratio 11.68).: Conclusions: Total lymphocytes; NLR; and levels of CD3+, CD4+ ... CD8+, and NK cells are useful as biomarkers of survival or mortality in severe COVID-19 disease and ...
Abstract | Background: Immune cell counts in blood in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection may be useful prognostic biomarkers of disease severity, mortality, and response to treatment. Objectives: To analyze sub-populations of lymphocytes at hospital admission in survivors and deceased from severe pneumonia due to coronavirus disease-2019 (COVID-19). Methods: We conducted a cross-sectional study of healthcare workers confirmed with SARS-CoV-2 in convalescents (control group) and healthy controls (HC) diagnosed with severe COVID-19. Serum samples were taken at hospital admission and after recovery. Serum samples ≥ 25 days after onset of symptoms were analyzed for lymphocyte subpopulations through flow cytometry. Descriptive statistics, Kruskall-Wallis test, receiver operating characteristic curve, calculation of sensitivity, specificity, predictive values, and Kaplan-Meier analysis were performed. Results: We included 337 patients: 120 HC, 127 convalescents, and 90 severe COVID-19 disease patients (50 survivors, 40 deceased). For T cells, total lymphocytes ≥ 800/μL, CD3+ ≥ 400/μL, CD4+ ≥ 180/μL, CD8+ ≥ 150/μL, B cells CD19+ ≥ 80/μL, and NK ≥ 34/μL subsets were associated with survival in severe COVID-19 disease patients. All subtypes of lymphocytes had higher concentrations in survivors than deceased, but similar between HC and convalescents. Leukocytes ≥ 10.150/μL or neutrophils ≥ 10,000/μL were associated with increased mortality. The neutrophil-to-lymphocyte ratio (NLR) ≥ 8.5 increased the probability of death in severe COVID-19 (odds ratio 11.68). Conclusions: Total lymphocytes; NLR; and levels of CD3+, CD4+, CD8+, and NK cells are useful as biomarkers of survival or mortality in severe COVID-19 disease and commonly reach normal levels in convalescents. |
---|---|
MeSH term(s) | Biomarkers/blood ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/pathology ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/mortality ; COVID-19/therapy ; Correlation of Data ; Cross-Sectional Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Killer Cells, Natural/pathology ; Leukocyte Count/methods ; Lymphopenia/blood ; Lymphopenia/diagnosis ; Lymphopenia/etiology ; Male ; Mexico/epidemiology ; Middle Aged ; Mortality ; Neutrophils/pathology ; Predictive Value of Tests ; Symptom Assessment/methods |
Chemical Substances | Biomarkers |
Language | English |
Publishing date | 2021-03-18 |
Publishing country | Israel |
Document type | Journal Article |
ZDB-ID | 2008291-5 |
ISSN | 1565-1088 ; 0021-2180 |
ISSN | 1565-1088 ; 0021-2180 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5470: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.